Previous 10 | Next 10 |
Shares of Fluidigm (NASDAQ: FLDM) rose over 58% today after the company announced it was selected to receive up to $37 million from the National Institutes of Health through the agency's Rapid Acceleration of Diagnostics (RADx) program. The funding is intended to develop methods for expandin...
Gainers: Sonnet BioTherapeutics (NASDAQ: SONN ) +97% . More news on: Sonnet BioTherapeutics Holdings, Inc., Zion Oil & Gas, Inc., Fluidigm Corporation, Stocks on the move, , Read more ...
Fluidigm ( FLDM +41.4% ) has executed a letter of contract with NIH and the National Institute of Biomedical Imaging and Bioengineering for a contract valued as high as $12M, based on certain deliverables, aimed at expanding production and throughput capacities for COVID-19 testing using...
Fluidigm ( FLDM +19.0% ) announces contract with the National Institutes of Health and National Institute of Biomedical Imaging and Bioengineering, for a proposed project under the agency’s Rapid Acceleration of Diagnostics ((RADx)) program. More news on: Fluidigm Corpora...
SOUTH SAN FRANCISCO, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced execution of a letter contract with the National Institutes ...
Test Intended to Expand Availability of COVID-19 Screening Resources in Central Ohio Workflow with Real-Time PCR Using Fluidigm Microfluidics Technology and Reagents Increasing Number of Labs Adopting the Fluidigm High-Throughput Testing Model SOUTH SAN FRANCISCO,...
DPW Holdings (NYSEMKT: DPW ) +136% on introducing a new product line of electric vehicle chargers. More news on: DPW Holdings, Inc., Sonnet BioTherapeutics Holdings, Inc., Volt Information Sciences, Inc., Stocks on the move, , Read more ...
IMV (NASDAQ: IMV ) +162% rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...
This article was highlighted for PRO subscribers, Seeking Alpha’s service for professional investors. Find out how you can get the best content on Seeking Alpha here . Executive Summary and Investment Conclusion After multiple years of negative earnings revisions and a stagnant r...
SOUTH SAN FRANCISCO, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report second quarter 2020 financial resul...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...